Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Account Payables (2016 - 2025)

Iradimed (IRMD) has disclosed Change in Account Payables for 13 consecutive years, with -$513069.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 32.17% to -$513069.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$76000.0 through Dec 2025, up 91.18% year-over-year, with the annual reading at -$76000.0 for FY2025, 91.18% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$513069.0 at Iradimed, down from $432494.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.6 million in Q2 2023, with the low at -$1.2 million in Q3 2023.
  • Average Change in Account Payables over 5 years is $47.5, with a median of $22117.5 recorded in 2021.
  • Peak annual rise in Change in Account Payables hit 2190.24% in 2022, while the deepest fall reached 6104.67% in 2022.
  • Over 5 years, Change in Account Payables stood at $47490.0 in 2021, then surged by 2190.24% to $1.1 million in 2022, then plummeted by 167.68% to -$736084.0 in 2023, then skyrocketed by 47.26% to -$388180.0 in 2024, then plummeted by 32.17% to -$513069.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$513069.0, $432494.0, and -$689064.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.